TherapeuticsMD Inc
TXMD1.120USD
+0.010+0.90%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
12.96MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über TherapeuticsMD Inc Unternehmen
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Unternehmensinformationen
BörsenkürzelTXMD
Name des UnternehmensTherapeuticsMD Inc
IPO-datumJan 31, 2001
CEOMr. Marlan D. Walker, J.D.
Anzahl der mitarbeiter1
WertpapierartOrdinary Share
GeschäftsjahresendeJan 31
Addresse951 Yamato Road, Suite 220
StadtBOCA RATON
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl33431
Telefon15619611900
Websitehttps://www.therapeuticsmd.com/
BörsenkürzelTXMD
IPO-datumJan 31, 2001
CEOMr. Marlan D. Walker, J.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
+3.94%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
+3.94%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Non-U.S
219.00K
55.73%
United States
174.00K
44.27%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Rubric Capital Management LP
25.46%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.30%
Tejara Capital Ltd.
2.98%
Adar1 Capital Management LLC
2.33%
Other
60.44%
Aktionäre
Aktionäre
Anteil
Rubric Capital Management LP
25.46%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.30%
Tejara Capital Ltd.
2.98%
Adar1 Capital Management LLC
2.33%
Other
60.44%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
33.68%
Investment Advisor
7.67%
Investment Advisor/Hedge Fund
1.60%
Individual Investor
1.55%
Research Firm
1.14%
Other
54.36%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
88
5.28M
45.65%
+1.46M
2025Q1
93
3.58M
30.94%
-393.28K
2024Q4
95
3.73M
32.32%
-2.03M
2024Q3
99
3.59M
31.15%
-463.34K
2024Q2
121
3.62M
31.37%
-2.25M
2024Q1
209
3.66M
32.13%
-802.21K
2023Q4
230
4.54M
44.12%
-1.60M
2023Q3
274
4.44M
43.31%
-158.22K
2023Q2
299
4.48M
44.55%
-545.84K
2023Q1
319
4.85M
52.06%
-356.05K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Rubric Capital Management LP
2.95M
25.46%
+1.75M
+147.18%
Apr 18, 2025
Clearline Capital LP
635.22K
5.49%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
381.94K
3.3%
-5.64K
-1.46%
Mar 31, 2025
Tejara Capital Ltd.
344.60K
2.98%
-50.07K
-12.69%
Mar 31, 2025
Adar1 Capital Management LLC
270.16K
2.33%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
130.12K
1.12%
-314.00
-0.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
116.13K
1%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
111.51K
0.96%
+3.17K
+2.93%
Mar 31, 2025
Walker (Marlan D)
73.64K
0.64%
+2.79K
+3.94%
Apr 18, 2025
Collins (Cooper C)
60.52K
0.52%
--
--
Apr 18, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
May 06, 2022
Merger
50<1
May 06, 2022
Merger
50<1
May 06, 2022
Merger
50<1
May 06, 2022
Merger
50<1
Datum
Art
Verhältnis
May 06, 2022
Merger
50<1
May 06, 2022
Merger
50<1
May 06, 2022
Merger
50<1
May 06, 2022
Merger
50<1
